Press Releases

Press releases and media publications regarding business development and scientific advances at Legend Biotech

May 30, 2018
Legend Announces FDA clearance of IND application on CAR-T immuno-cell therapy for the Treatment of Multiple Myeloma
Mar 13, 2018
Nanjing Legend formally received the permission of a clinical trial granted by the CFDA with respect to LCARB38M CAR-T for autologous infusion
Dec 22, 2017
Legend Biotech Announces Closing of Global Strategic LCAR-B38M Car-T Cell Immunotherapy Collaboration with Janssen
Dec 11, 2017
The application for investigational new drug by Nanjing Legend was accepted by the CFDA